Western blot analysis indicated that SB203580 treatment combined with DDP significantly reduced the expression of the hallmark of p38 MAPK genes MKK6, p38α, and p-p38α in ESCC cells compared with that of single SB203580 treatment. This evidence concerns the gene MAP2K6 and esophageal squamous cell carcinoma.